Skip to content
FTC, States Ask Federal Court to Hold Martin Shkreli in Contempt for Allegedly Violating Lifetime Ban from Pharmaceutical Industry

FTC, States Ask Federal Court to Hold Martin Shkreli in Contempt for Allegedly Violating Lifetime Ban from Pharmaceutical Industry

Articleftc.gov

Commission cites evidence it alleges shows that Shkreli repeatedly violated a 2022 order that banned him from working in the pharmaceutical industry for life The Federal Trade Commission and seven states today asked a federal judge to hold Martin Shkreli in contempt based on their allegations that he flagrantly and repeatedly violated a 2022 court order that banned him from the pharmaceutical industry. View Press Release

Source: FTC Press ReleasesPublished: Oct 13, 2026

Last updated Oct 14, 2026 by ATDb automated enrichment